Paediatric MOG antibody-associated ADEM with complex movement disorder: A case report

Mult Scler. 2019 Jan;25(1):125-128. doi: 10.1177/1352458518786074. Epub 2018 Oct 31.

Abstract

Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are a well-recognized cause of acquired demyelinating syndromes in both adult and children. Despite basal ganglia involvement on imaging, movement disorder is not a cardinal feature. We describe a 2-year-9-month-old girl who presented with severe encephalopathy with aphasia, seizures and a complex movement disorder with dystonic posturing and tonic eye deviation. Neuroimaging revealed subtle asymmetrical predominantly white matter signal changes. MOG-Abs were positive in the serum. Other known pathogenic autoantibodies including N-methyl-D-aspartate receptor antibodies (NMDAR-Abs) were negative. The patient made a complete recovery following 2-week corticosteroid treatment. This case highlights the need for MOG-Ab testing in children with suspected autoimmune encephalopathies.

Keywords: EEG; MRI; immunology; treatment response.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / pharmacology
  • Child, Preschool
  • Encephalomyelitis, Acute Disseminated / complications
  • Encephalomyelitis, Acute Disseminated / diagnosis*
  • Encephalomyelitis, Acute Disseminated / drug therapy
  • Encephalomyelitis, Acute Disseminated / immunology
  • Female
  • Humans
  • Movement Disorders / diagnosis*
  • Movement Disorders / drug therapy
  • Movement Disorders / etiology
  • Movement Disorders / immunology
  • Myelin-Oligodendrocyte Glycoprotein / immunology*

Substances

  • Adrenal Cortex Hormones
  • MOG protein, human
  • Myelin-Oligodendrocyte Glycoprotein